Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 2,467,809 3.500% | -1,911,010 (-43.64%) | Filing History |
| 2024-11-14 5:54 pm Sale | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,418,068 4.900% | -2,857,142 (-45.53%) | Filing History |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Nextech Crossover I GP S.a r.l. | 5,285,714 7.500% | 1,000,000 (+23.33%) | Filing History |
| 2024-11-14 5:14 pm Sale | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 3,644,118 5.200% | -27,404 (-0.75%) | Filing History |
| 2024-11-13 09:42 am Purchase | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | ALKEON CAPITAL MANAGEMENT LLC | 3,904,096 5.500% | 300,000 (+8.32%) | Filing History |
| 2024-11-12 10:32 am Sale | 2024-11-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 4,378,819 6.207% | -715,910 (-14.05%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 5,101,817 7.200% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 5,101,817 7.200% | 2,106,785 (+70.34%) | Filing History |
| 2024-03-11 08:19 am Sale | 2024-03-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,094,729 7.562% | -1,907,379 (-27.24%) | Filing History |
| 2024-02-14 6:19 pm Purchase | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 6,275,210 8.900% | 2,857,142 (+83.59%) | Filing History |
| 2024-02-13 6:43 pm Purchase | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | ALKEON CAPITAL MANAGEMENT LLC | 3,604,096 6.600% | 1,204,844 (+50.22%) | Filing History |
| 2024-02-13 09:26 am Sale | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Prosight Management LP | 1,578,263 2.900% | -702,515 (-30.80%) | Filing History |
| 2024-02-09 09:28 am Purchase | 2024-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 7,002,108 12.835% | 2,985,500 (+74.33%) | Filing History |
| 2024-02-07 5:09 pm Sale | 2024-01-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 2,995,032 4.500% | -100,616 (-3.25%) | Filing History |
| 2024-02-06 4:12 pm Sale | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | MILLENNIUM MANAGEMENT LLC | 0 0.000% | -2,433,850 (Position Closed) | Filing History |
| 2024-02-01 4:15 pm Purchase | 2024-01-22 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III, L.P. | 4,428,385 6.600% | 4,428,385 (New Position) | Filing History |
| 2024-01-30 4:31 pm Purchase | 2024-01-20 | 13G | ORIC Pharmaceuticals, Inc. ORIC | VIKING GLOBAL INVESTORS LP | 4,000,000 5.900% | 4,000,000 (New Position) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 3,095,648 5.700% | 2,296,307 (+287.28%) | Filing History |
| 2024-01-25 1:24 pm Purchase | 2024-01-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Frazier Life Sciences Public Fund, L.P. | 4,142,855 6.200% | 4,142,855 (New Position) | Filing History |
| 2023-07-07 4:15 pm Purchase | 2023-06-27 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Nextech Crossover I GP S.a r.l. | 4,285,714 7.900% | 4,285,714 (New Position) | Filing History |